-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
The challenges of dengue drug discovery and development
Feng Gu, Pei-Yong Shi
Editorial: Clinical Investigation
-
The challenges of dengue drug discovery and development
Feng Gu, Pei-Yong Shi
Editorial: Clinical Investigation
-
The challenges of dengue drug discovery and development
Feng Gu, Pei-Yong Shi
Editorial: Clinical Investigation
-
The challenges of dengue drug discovery and development
Feng Gu, Pei-Yong Shi
Editorial: Clinical Investigation
-
The challenges of dengue drug discovery and development
Feng Gu, Pei-Yong Shi
Editorial: Clinical Investigation
-
The challenges of dengue drug discovery and development
Feng Gu, Pei-Yong Shi
Editorial: Clinical Investigation
-
The challenges of dengue drug discovery and development
Feng Gu, Pei-Yong Shi
Editorial: Clinical Investigation
-
The challenges of dengue drug discovery and development
Feng Gu, Pei-Yong Shi
Editorial: Clinical Investigation
-
Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data
Donald Banerji, Robert Fogel & Kai-Michael Beeh
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data
Donald Banerji, Robert Fogel & Kai-Michael Beeh
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data
Donald Banerji, Robert Fogel & Kai-Michael Beeh
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data
Donald Banerji, Robert Fogel & Kai-Michael Beeh
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data
Donald Banerji, Robert Fogel & Kai-Michael Beeh
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data
Donald Banerji, Robert Fogel & Kai-Michael Beeh
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data
Donald Banerji, Robert Fogel & Kai-Michael Beeh
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data
Donald Banerji, Robert Fogel & Kai-Michael Beeh
Review: Clinical Trail Outcomes: Clinical Investigation
-
Nocturia, of clinical importance
Jennifer G Rothschild, David J Osborn, Melissa R Kaufman , Roger R Dmochowski
Editorial: Clinical Investigation
-
Nocturia, of clinical importance
Jennifer G Rothschild, David J Osborn, Melissa R Kaufman , Roger R Dmochowski
Editorial: Clinical Investigation
-
Nocturia, of clinical importance
Jennifer G Rothschild, David J Osborn, Melissa R Kaufman , Roger R Dmochowski
Editorial: Clinical Investigation
-
Nocturia, of clinical importance
Jennifer G Rothschild, David J Osborn, Melissa R Kaufman , Roger R Dmochowski
Editorial: Clinical Investigation
-
Nocturia, of clinical importance
Jennifer G Rothschild, David J Osborn, Melissa R Kaufman , Roger R Dmochowski
Editorial: Clinical Investigation
-
Nocturia, of clinical importance
Jennifer G Rothschild, David J Osborn, Melissa R Kaufman , Roger R Dmochowski
Editorial: Clinical Investigation
-
Nocturia, of clinical importance
Jennifer G Rothschild, David J Osborn, Melissa R Kaufman , Roger R Dmochowski
Editorial: Clinical Investigation
-
Nocturia, of clinical importance
Jennifer G Rothschild, David J Osborn, Melissa R Kaufman , Roger R Dmochowski
Editorial: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomes: Clinical Investigation
-
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Clinical Trail Perspective: Clinical Investigation
-
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Clinical Trail Perspective: Clinical Investigation
-
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Clinical Trail Perspective: Clinical Investigation
-
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Clinical Trail Perspective: Clinical Investigation
-
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Clinical Trail Perspective: Clinical Investigation
-
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Clinical Trail Perspective: Clinical Investigation
-
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Clinical Trail Perspective: Clinical Investigation
-
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Clinical Trail Perspective: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Impact of recent landmark clinical trials on hypertension treatment
Ikechi G Okpechi, Brian L Rayner
Review Article: Clinical Investigation
-
Impact of recent landmark clinical trials on hypertension treatment
Ikechi G Okpechi, Brian L Rayner
Review Article: Clinical Investigation
-
Impact of recent landmark clinical trials on hypertension treatment
Ikechi G Okpechi, Brian L Rayner
Review Article: Clinical Investigation
-
Impact of recent landmark clinical trials on hypertension treatment
Ikechi G Okpechi, Brian L Rayner
Review Article: Clinical Investigation
-
Impact of recent landmark clinical trials on hypertension treatment
Ikechi G Okpechi, Brian L Rayner
Review Article: Clinical Investigation
-
Impact of recent landmark clinical trials on hypertension treatment
Ikechi G Okpechi, Brian L Rayner
Review Article: Clinical Investigation
-
Impact of recent landmark clinical trials on hypertension treatment
Ikechi G Okpechi, Brian L Rayner
Review Article: Clinical Investigation
-
Impact of recent landmark clinical trials on hypertension treatment
Ikechi G Okpechi, Brian L Rayner
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation